CAS 835621-07-3: 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, hydrochloride (1:1)

Formel: C₂₁H₁₅ClF₄N₄O₃·ClH

InChl: InChI=1S/C21H15ClF4N4O3.ClH/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H

InChI Key: InChIKey=ACSWJKPZXNIVMY-UHFFFAOYSA-N

SMILES: Cl.O=C(NC1=CC=C(Cl)C(=C1)C(F)(F)F)NC2=CC=C(OC=3C=CN=C(C3)C(=O)NC)C=C2F

Synonyme:

• 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, hydrochloride (1:1)
• 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, monohydrochloride
• Regafenib hydrochloride

Regorafenib (Hydrochloride)

CAS: 835621-07-3

• Formel: C₂₁H₁₆Cl₂F₄N₄O₃
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 519.2764

Regorafenib Hydrochloride

CAS: 835621-07-3

Regorafenib HCl (BAY73-4506) is an oral inhibitor targeting angiogenic, stromal, and cancer kinases with strong …

• Formel: C₂₁H₁₆Cl₂F₄N₄O₃
• Reinheit: 100%
• Farbe und Form: Solid
• Molekulargewicht: 519.28

Regorafenib hydrochloride

CAS: 835621-07-3

Multi-kinase inhibitor; inhibits epoxide hydrolase; antineoplastic

• Formel: C₂₁H₁₅ClF₄N₄O₃•HCl
• Reinheit: Min. 95%
• Molekulargewicht: 519.28 g/mol